Amanote Research

Amanote Research

    RegisterSign In

mRNA Vaccine CV9103 and CV9104 for the Treatment of Prostate Cancer

Human Vaccines and Immunotherapeutics - United States
doi 10.4161/hv.29553
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineAllergyImmunologyPharmacology
Date

November 1, 2014

Authors
Steffen RauschChristian SchwentnerArnulf StenzlJens Bedke
Publisher

Informa UK Limited


Related search

Vaccine Immunotherapy for Prostate Cancer

2012English

The Bacterial Vaccine Treatment of Cancer

BMJ
1906English

The Bacterial Vaccine Treatment of Cancer

BMJ
1906English

Prostate Cancer Treatment and Survival

Medical Care
EnvironmentalPublic HealthOccupational Health
2014English

Apalutamide for the Treatment of Non‐metastatic Prostate Cancer

Prescriber
Pharmacology
2019English

Focal Treatment on Prostate Cancer: The 3 Dilemmas Debating Focal Therapy for Prostate Cancer

Experimental Techniques in Urology & Nephrology
2018English

Advances in Radiotherapy for Prostate Cancer Treatment

Advances in Experimental Medicine and Biology
BiochemistryMedicineGeneticsMolecular Biology
2018English

APC8015, a Therapeutic Vaccine for Prostate Cancer, Targets Prostatic Acid Phosphatase

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2005English

Adherence to Dietary and Lifestyle Recommendations and Prostate Cancer Risk in the Prostate Testing for Cancer and Treatment (ProtecT) Trial

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy